MONTREAL and CHARLOTTE, N.C., Nov. 23, 2020 /CNW/ -- Milestone
Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical
company focused on the development and commercialization of
innovative cardiovascular medicines, today announced
that Joseph Oliveto, President and Chief Executive Officer,
will present at the following investor conferences:
- The Piper Sandler 32nd Virtual Annual Healthcare
Conference.
- The Evercore ISI 3rd Annual HealthCONx Conference on
Thursday, December 3, 2020 at
4:20 p.m. Eastern Time.
A replay of the pre-recorded Piper Sandler fireside chat is
currently available in the News & Events section of Milestone's
website at www.milestonepharma.com, and a live webcast of the
Evercore fireside chat can be accessed in the same section of
Milestone's website. An archived replay of the webcasts will be
available on the same website for approximately 90 days following
the presentations.
About Milestone Pharmaceuticals
Milestone Pharmaceuticals is a biopharmaceutical company focused
on the development and commercialization of etripamil, a Phase 3
clinical-stage program, for the treatment of cardiovascular
indications. Milestone Pharmaceuticals operates in Canada and the
United States. For more information, visit
www.milestonepharma.com and follow the Company on Twitter at
@MilestonePharma.
Contact
David Pitts
Argot Partners
212-600-1902
david@argotpartners.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/milestone-pharmaceuticals-to-present-at-upcoming-investor-conferences-301178279.html
SOURCE Milestone Pharmaceuticals, Inc.